Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience.
about
Afatinib-Associated Cutaneous Toxicity: A Correlation of Severe Skin Reaction with Dramatic Tumor Response in a Woman with Exon 19 Deletion Positive Non-Small-Cell Lung Cancer.Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659E.Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer.
P2860
Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Development of a skin rash wit ...... Cancer Study Group experience.
@en
Development of a skin rash wit ...... ant non-small cell lung cancer
@nl
type
label
Development of a skin rash wit ...... Cancer Study Group experience.
@en
Development of a skin rash wit ...... ant non-small cell lung cancer
@nl
prefLabel
Development of a skin rash wit ...... Cancer Study Group experience.
@en
Development of a skin rash wit ...... ant non-small cell lung cancer
@nl
P2093
P2860
P1476
Development of a skin rash wit ...... Cancer Study Group experience.
@en
P2093
Akihiro Bessho
Katsuyuki Hotta
Kenichi Gemba
Kenichiro Kudo
Koji Inoue
Masanori Fujii
Nagio Takigawa
Naohiro Oda
Naoyuki Nogami
Shingo Harita
P2860
P2888
P304
P356
10.1007/S00280-015-2910-9
P577
2016-03-31T00:00:00Z